Left ventricular geometry and cardiovascular mortality based on haemodialysis patient autopsy analyses

Nephrology

Volumn 15, Issue 5, 2010, Pages 549-554

  Mimura, Imari ^a,b   Nishi, Hiroshi ^a   Mise, Naobumi ^b   Mori, Masaya ^b   Sugimoto, Tokuichiro ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b MITSUI MEMORIAL HOSPITAL   (Japan)

Author keywords

autopsy; cardiovascular disease; haemodialysis; left ventricular hypertrophy; mortality

Indexed keywords

ARTICLE; AUTOPSY; BODY WEIGHT; CAUSE OF DEATH; CONTROLLED STUDY; GEOMETRY; HEART DILATATION; HEART LEFT VENTRICLE MASS; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEMODIALYSIS PATIENT; HISTOPATHOLOGY; HUMAN; JAPAN; KIDNEY FAILURE; MORPHOLOGY; MORTALITY; PRIORITY JOURNAL; AGED; CARDIOVASCULAR DISEASES; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; COMPLICATION; CROSS-SECTIONAL STUDY; FEMALE; FIBROSIS; HEART VENTRICLE; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MALE; PATHOLOGY; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

AGED; AUTOPSY; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; FIBROSIS; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; JAPAN; KIDNEY FAILURE, CHRONIC; MALE; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 77955084587     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2010.01266.x     Document Type: Article

References (18)

1. United States Renal Data System 2006. Annual Data Report - Atlas of Chronic Kidney Disease and End-stage Renal Disease in the United States. Morbidity and Mortality. Am. J. Kidney Dis. 2007 49 (Suppl 1 S1 146.
2. Venkatesan J, Henrich WL. Anemia, hypertension, and myocardial dysfunction in end-stage renal disease. Semin. Nephrol. 1997 17 : 257 269.
3. Nakai S, Masakane I, Shigematsu T et al. An overview of regular dialysis treatment in Japan (as of 31 December 2007). Ther. Apher. Dial. 2009 13 : 457 504.
4. Churchill DN, Taylor DW, Cook RJ et al. Canadian hemodialysis morbidity study. Am. J. Kidney Dis. 1992 19 : 214 234.
5. Trespalacios FC, Taylor AJ, Agodoa LY, Bakris GL, Abbott KC. Heart failure as a cause for hospitalization in chronic dialysis patients. Am. J. Kidney Dis. 2003 41 : 1267 1277.
6. Middleton RJ, Parfrey PS, Foley RN. Left ventricular hypertrophy in the renal patient. J. Am. Soc. Nephrol. 2001 12 : 1079 1084.
7. Stewart GA, Gansevoort RT, Mark PB et al. Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney Int. 2005 67 : 217 226.
8. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J. Am. Soc. Nephrol. 1995 5 : 2024 2031.
9. Foley RN, Parfrey PS, Harnett JD et al. Clinical and echocardiographic disease in patients with starting end-stage renal disease therapy: Prevalence, associations and prognosis. Kidney Int. 1995 47 : 186 192.
10. Huwez FU, Pringle SD, Macfarlane PW. A new classification of left ventricular geometry in patients with cardiac disease based on M-mode echocardiography. Am. J. Cardiol. 1992 70 : 681 688.
11. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uremia. Nephrol. Dial. Transplant. 1996 11 : 1277 1285.
12. London GM, Fabiani F, Marchais SJ et al. Uremic cardiomyopathy: An inadequate left ventricular hypertrophy. Kidney Int. 1987 31 : 973 980.
13. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE. Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J. Am. Soc. Nephrol. 2000 11 : 912 916.
14. Aoki J, Ikari Y, Nakajima H et al. Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients. Kidney Int. 2005 67 : 333 340.
15. Anker SD, Steinborn W, Strassburg S. Cardiac cachexia. Ann. Med. 2004 36 : 518 529.
16. Ribeiro S, Ramos A, Brandao A et al. Cardiac valve calcification in haemodialysis patients: Role of calcium-phosphate metabolism. Nephrol. Dial. Transplant. 1998 13 : 2037 2040.
17. Wang AY, Wang M, Woo J et al. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: A prospective study. J. Am. Soc. Nephrol. 2003 14 : 159 168.
18. Ventura JE, Tavella N, Romero C, Petraglia A, Baez A, Munoz L. Aortic valve calcification is an independent factor of left ventricular hypertrophy in patients on maintenance haemodialysis. Nephrol. Dial. Transplant. 2002 17 : 1795 1801.